By using human X-ALD fibroblasts and a zebrafish Abcd1 mutant model, metabolic rerouting of saturated to monounsaturated VLCFAs by SCD1 was found to attenuate lipid toxicity (Fig. 1) [19]. Here, ABCD1 is linked to X-linked adrenoleukodystrophy.